IL6 and cancer: In colorectal cancer, TAMs activate the IL-6/STAT3/miR-204-5p pathway by secreting IL-6, which supports cancer progression, increases the resistance of colorectal cancer to chemotherapeutic drugs and reduces drug-induced apoptosis [25].